Yongqian Shu

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 6

Top Topics

Randomized Controlled Trial

Squamous Cell Carcinoma

Long Noncoding Rna

Top Venues

Molecular cancer

Cancer medicine

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Jing Huang, Juxiang Xiao, Wentao Fang, Ping Lu, Qingxia Fan, Yongqian Shu, Jifeng Feng, Shu Zhang, Yi Ba, Yang Zhao, Ying Liu, Chunmei Bai, Yuxian Bai, Yong Tang, Yan Song, Jie He
Anlotinib for previously treated advanced or metastatic esophageal squamous cell carcinoma: A double-blind randomized phase 2 trial. Cancer medicine 10 (5) (2021)
Mengyan Xie, Tao Yu, Xinming Jing, Ling Ma, Yu Fan, Fengming Yang, Pei Ma, Huning Jiang, Xi Wu, Yongqian Shu, Tongpeng Xu
Exosomal circSHKBP1 promotes gastric cancer progression via regulating the miR-582-3p/HUR/VEGF axis and suppressing HSP90 degradation. Molecular cancer 19 (1) (2020)
Chuchu Shao, Fengming Yang, Zhiqiang Qin, Xinming Jing, Yongqian Shu, Hua Shen
The value of miR-155 as a biomarker for the diagnosis and prognosis of lung cancer: a systematic review with meta-analysis. BMC cancer 19 (1) (2019)
Fengming Yang, Chuchu Shao, Ke Wei, Xinming Jing, Zhiqiang Qin, Yuenian Shi, Yongqian Shu, Hua Shen
miR-942 promotes tumor migration, invasion, and angiogenesis by regulating EMT via BARX2 in non-small-cell lung cancer. Journal of cellular physiology 234 (12) (2019)
Xinming Jing, Fengming Yang, Chuchu Shao, Ke Wei, Mengyan Xie, Hua Shen, Yongqian Shu
Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Molecular cancer 18 (1) (2019)
Fengming Yang, Zhiqiang Qin, Chuchu Shao, Weitao Liu, Ling Ma, Yongqian Shu, Hua Shen
Association between VEGF Gene Polymorphisms and the Susceptibility to Lung Cancer: An Updated Meta-Analysis. BioMed research international 2018 (2018)